AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Implantable Pulse Generator Market Expected to Grow with a CAGR of 9.86% During the Forecast Period, 2019-2024 - ResearchAndMarkets.com

November 27, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Nov 27, 2019--

The “Implantable Pulse Generator Market - Forecasts from 2019 to 2024” report has been added to ResearchAndMarkets.com’s offering.

Implantable pulse generator market is projected to grow at a CAGR of 9.86% during the forecast period, reaching a total market size of US$4.167 billion in 2024 from US$2.370 billion in 2018.

An Implantable pulse generator is a battery-powered micro-electronic device, implanted in the body, which delivers electrical stimulation to the nervous system. Increasing prevalence of diseases and growing demand for innovative alternate therapies are the key driving factors that are boosting the demand for the implantable pulse generators. Other significant drivers fueling the increasing penetration of implantable pulse generators include ease of implants with enhanced clinical performance, good reimbursements, greater patient awareness, and advancing technology. The market is expected to grow at a steady pace owing to its increasing use to treat a wide array of medical conditions and diseases.

Geographically, the implantable pulse generator is segmented as North America, Europe, Middle East & Africa, Asia-Pacific, and South America. North America holds a significant market share owing to the favorable reimbursement policies and sophisticated health infrastructure. The Asia Pacific is expected to grow at a significant rate owing to the advancing healthcare infrastructure and decreasing prices for implants in this region.

The Implantable Pulse Generator Market - Forecasts from 2019 to 2024 is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by product type, application, end-user, and geography.

Key Topics Covered:

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Currency

1.5. Assumptions

1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design

2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Porter’s Five Force Analysis

4.5.1 Bargaining Power of Suppliers

4.5.2 Bargaining Power of Buyers

4.5.3 Threat of New Entrants

4.5.4 Threat of Substitutes

4.5.5 Competitive Rivalry in the Industry

4.6. Life Cycle Analysis - Regional Snapshot

4.7. Market Attractiveness

5. IMPLANTABLE PULSE GENERATOR MARKET BY PRODUCT TYPE

5.1. Implantable Cardiac Pacemaker

5.2. Implantable Spinal Cord Stimulator

5.3. Implantable Defibrillator

5.4. Others

6. IMPLANTABLE PULSE GENERATOR MARKET BY APPLICATION

6.1. Cardiovascular Diseases

6.2. Neurovascular Diseases

6.3. Orthopedic

7. IMPLANTABLE PULSE GENERATOR MARKET BY END-USER

7.1. Hospitals and Clinics

7.2. Ambulatory Surgical Centers

7.3. Homecare Settings

8. IMPLANTABLE PULSE GENERATOR MARKET BY GEOGRAPHY

8.1. North America

8.1.1. USA

8.1.2. Canada

8.1.3. Mexico

8.2. South America

8.2.1. Brazil

8.2.2. Argentina

8.2.3. Others

8.3. Europe

8.3.1. Germany

8.3.2. France

8.3.3. United Kingdom

8.3.4. Spain

8.3.5. Others

8.4. Middle East and Africa

8.4.1. Israel

8.4.2. Saudi Arabia

8.4.3. Others

8.5. Asia Pacific

8.5.1. China

8.5.2. Japan

8.5.3. South Korea

8.5.4. India

8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Competitive Benchmarking and Analysis

9.2. Recent Investment and Deals

9.3. Strategies of Key Players

10. COMPANY PROFILES

10.1. Medtronic, Inc.

10.2. Abbott

10.3. Dextronix, Inc.

10.4. Nevro Corp

10.5. Integer Holdings Corporation

10.6. Boston Scientific Corporation

10.7. NeuroSigma, Inc.

10.8. Cyberonics, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/e34z7r

View source version on businesswire.com:https://www.businesswire.com/news/home/20191127005271/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/27/2019 05:11 AM/DISC: 11/27/2019 05:11 AM

http://www.businesswire.com/news/home/20191127005271/en